Stockscreener 앱 받기
6.00
2.76%
-0.17
시간 외 거래:
5.99
-0.010
-0.17%
전일 마감가:
$6.17
열려 있는:
$6.15
하루 거래량:
177.46K
Relative Volume:
1.18
시가총액:
$125.36M
수익:
-
순이익/손실:
$-22.38M
주가수익비율:
-4.2553
EPS:
-1.41
순현금흐름:
$-15.54M
1주 성능:
-11.76%
1개월 성능:
-20.84%
6개월 성능:
-10.58%
1년 성능:
-12.28%
1일 변동 폭
$5.85
$6.505
1주일 범위
$5.85
$7.38
52주 변동 폭
$4.44
$11.80
Nuvectis Pharma Inc Stock (NVCT) Company Profile
명칭
Nuvectis Pharma Inc
전화
360-837-7232
주소
1 BRIDGE PLAZA, SUITE 275, FORT LEE
NVCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
6.00 | 134.97M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Maxim Group | Buy |
| 2025-03-17 | 개시 | Laidlaw | Buy |
| 2022-07-13 | 개시 | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc 주식(NVCT)의 최신 뉴스
How to track smart money flows in Nuvectis Pharma Inc.Strategy Builder for Growth Focused Traders - Newser
Volume spikes in Nuvectis Pharma Inc. stock – what they meanFree Pattern Detection for Entry Confirmation - Newser
Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) stock price dropped 12% last week; retail investors would not be happy - simplywall.st
Developing predictive dashboards with Nuvectis Pharma Inc. dataFree Proven Entry Plan With Low Risk Trade - Newser
Does Nuvectis Pharma Inc. fit your quant trading modelFree Exit Ready Momentum Stock Watchlist - Newser
Key resistance and support levels for Nuvectis Pharma Inc.Free Low Risk Picks for Daily Trading - Newser
Will Nuvectis Pharma Inc. stock recover after recent dropReal Time Trade Execution Alert Plan - Newser
How to forecast Nuvectis Pharma Inc. trends using time seriesWatchlist Generator for Smart Money Signals - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionFree Expert Verified Stock Trade Ideas - Newser
Nuvectis Pharma cuts NXP800 in ovarian cancer after early failure - MSN
Nuvectis Pharma Inc. stock daily chart insightsSwing Watchlist With Tight Stop Placement - Newser
Nuvectis Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingTrend Reversal Watch with Entry Signals - Newser
Using R and stats models for Nuvectis Pharma Inc. forecastingFree Trade Ready Stock Watch for Short Term - Newser
Is Nuvectis Pharma Inc. trending in predictive chart modelsNext Day Momentum Stock Forecasting Report - Newser
Q3 EPS Estimates for Nuvectis Pharma Reduced by Roth Capital - Defense World
Will a bounce in Nuvectis Pharma Inc. offer an exitFree Consistent Profit Pattern Recognition Tools - Newser
What indicators show strength in Nuvectis Pharma Inc.Free Real Time Alerts Based on AI Prediction - Newser
what makes nuvectis pharma inc. stock price move sharplyHigh Probability Trade Outcome Prediction - Newser
Nuvectis Pharma’s Strategic Focus on NXP900 and Positive Outlook Amidst Promising Developments - TipRanks
Nuvectis Pharma Reports Q2 2025 Financial Results and Progress - TipRanks
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Stable Profit Zone and Loss Control Analysis - Newser
Nuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year - TipRanks
Nuvectis Pharma: A Biotech Gem in the Shadows of GAAP Losses - AInvest
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Nuvectis Reports Clinical Trial Success: NXP900 Cancer Drug Advances as Cash Position Strengthens to $39M - Stock Titan
Nuvectis Pharma (NASDAQ:NVCT) Given a $10.00 Price Target by HC Wainwright Analysts - Defense World
Nuvectis Pharma (NASDAQ:NVCT) PT Set at $10.00 by HC Wainwright - Defense World
What makes Nuvectis Pharma Inc. stock price move sharplyFree Swing Trading Plan With Smart Signals - Newser
Nuvectis Pharma: Reprioritized Pipeline and Promising Clinical Progress Supports Buy Rating - AInvest
Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright - Investing.com Nigeria
Nuvectis Pharma Inc. stock volume spike explainedLong Term Equity Screener with Safety Metrics - Newser
Nuvectis Pharma Inc (NVCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):